Infant Phototherapy Market Outlook
The Global Infant Phototherapy Device Market was valued at US$ 96.44 million in 2023 and is projected to grow at a CAGR of 3.89% from 2024 to 2032, reaching US$ 135.97 million by 2032, according to Renub Research.
Phototherapy devices play a crucial role in treating infant jaundice, a condition frequently observed in newborns due to elevated bilirubin levels. These devices utilize specific wavelengths of light to convert bilirubin into a water-soluble form that can be easily excreted. This non-invasive and efficient treatment ensures newborns receive timely care, significantly reducing health complications.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=infant-phototherapy-device-market-p.php
Infant Population and Birth Trends Worldwide
Population and birth trends are key drivers of the infant phototherapy market.
- United States: According to the CDC, 3,664,292 births were recorded in 2021, with a fertility rate of 56.3 per 1,000 women aged 15–44.
- India: The National Population Register reports that India has the highest number of annual births, with an estimated 24 million.
- China: Following policy changes, including the three-child policy in 2021, 9.02 million births were recorded in 2023.
- France: INSEE reported 678,000 births in 2023, with a fertility rate of 1.68 children per woman.
The global birth rates and increasing awareness of neonatal care bolster the demand for phototherapy devices.
Rising Prevalence of Neonatal Jaundice
Neonatal jaundice affects 60% of full-term babies and 80% of preterm babies, according to the Children's Liver Disease Foundation. The condition peaks around the fourth day of life and resolves in most infants by two weeks. However, severe cases require phototherapy to prevent complications, boosting device adoption.
Advancements in technology also enhance accessibility and efficiency. Portable phototherapy units, like the BilliTouch phototherapy blanket launched by Motif Medical in 2021, allow parents to administer treatment at home without separating from their newborns.
North America: A Key Regional Market
North America leads in the adoption of infant phototherapy devices, supported by advanced healthcare infrastructure and robust research standards. According to the CDC, one in ten babies born in the U.S. in 2022 was preterm, highlighting the need for phototherapy in neonatal care.
Regulatory support and widespread awareness among healthcare providers further strengthen the market.
Related Report:
Italy In-Vitro Diagnostics Market
Europe In-Vitro Diagnostics Market
Competitive Landscape
The global infant phototherapy device market features prominent players such as:
- Ningbo David Medical Device Co., Ltd.
- Koninklijke Philips N.V.
- General Electric Company
- Drägerwerk AG & Co. KGaA
- Natus Medical Incorporated
Recent innovations and acquisitions have enriched their product portfolios:
- Dräger: Developing intelligent ICU technologies with funding from the Innovative Health Initiative (2023).
- GenWorks: Launched Billicare, a noninvasive bilirubin assessment tool (2022).
- NeoLight: Acquired Phoenix Technology Group to expand neonatal care offerings (2021).
Market Segmentation
By Light Source:
- Fluorescent Lamps
- Light Emitting Diodes (LEDs)
- Quartz Halogen Lamps
- Gas Discharge Tubes
By Configuration:
- Mobile Devices
- Fixed Devices
By End User:
- Hospitals
- Neonatal Clinics
By Region:
25 countries across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Key Insights
- Base Year: 2022
- Historical Period: 2017–2022
- Forecast Period: 2023–2032
- Customization Scope: Up to 20% free customization available
About Us - Renub Research
Renub Research is a premier Market Research and Advisory company with over 15 years of experience in Business-to-Business Global Market Research, Business Surveys, and Management Consulting. We provide a wide range of specialized business research services designed to help organizations make informed decisions and achieve their highest potential.
We work closely with our clients to understand the challenges they face and offer actionable insights to address these challenges. Our services are aimed at identifying the necessary changes and strategic adjustments needed for companies to succeed in today’s competitive market. Our clients include leading organizations from a wide range of industries such as Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecommunications & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture.
At Renub Research, we provide our clients with detailed and accurate market data to support decision-making based on both information and knowledge. Our firm is recognized for delivering comprehensive industry solutions that aid consultants, bankers, and executives in formulating effective business strategies and making sound management decisions.
Our team comprises skilled professionals with expertise across various fields, including finance, marketing, human resources, biotechnology, pharmaceuticals, IT, environmental science, and more. The insights derived from our studies form the foundation for crucial management decisions, such as strategies, organizational structure, technology adoption, and mergers and acquisitions.
We take pride in supporting top global players, providing not only IT solutions but also comprehensive market trend analysis and opportunities. Our research reports offer critical tools for managers in today’s competitive global economy, featuring information and insights, analysis and understanding, as well as forecasts and estimations to guide decision-making
